JENNIFER MILAM: Open Payments
NPI 1346838216 · BRANDON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 8 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $388 · 2025 $772
Food & beverage: $759Education: $12
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $147 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $137 |
| Vanda Pharmaceuticals Inc. | 1 | $119 |
| Dexcom, Inc. | 1 | $107 |
| Boston Scientific Corporation | 1 | $102 |
| EVOKE PHARMA, INC. | 1 | $81 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $79 |
Products named: REXULTI, CAPLYTA, FANAPT, DEXCOM G7 GSS (161), WATCHMAN FLX, GIMOTI, LifeVest.
Industry payments across FL — which companies pay providers there.
